Literature DB >> 32114853

Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit.

Jacopo Burrello1, Silvia Monticone1, Isabel Losano1, Giovanni Cavaglià1, Fabrizio Buffolo1, Martina Tetti1, Michele Covella1, Franco Rabbia1, Franco Veglio1, Barbara Pasini2, Tracy Ann Williams1,3, Paolo Mulatero1.   

Abstract

Primary aldosteronism (PA) was considered a rare disorder almost always associated with hypokalemia. The widespread screening of patients with hypertension unveiled an increased prevalence of PA with normokalemic hypertension the prevailing phenotype. Many studies have reported the prevalence of hypokalemia in patients with PA; conversely, the prevalence of PA in patients with hypokalemia is unknown. In this retrospective observational study, we define the prevalence of hypokalemia in referred patients with hypertension and the prevalence of PA in patients with hypokalemia and hypertension. Hypokalemia was present in 15.8% of 5100 patients with hypertension, whereas 76.9% were normokalemic, and 7.3% hyperkalemic. The prevalence of PA in patients with hypokalemia was 28.1% and increased with decreasing potassium concentrations up to 88.5% of patients with spontaneous hypokalemia and potassium concentrations <2.5 mmol/L. A multivariate regression analysis demonstrated the association of hypokalemia with the occurrence of cardiovascular events independent of PA diagnosis. An association of PA with the occurrence of cardiovascular events and target organ damage independent of hypokalemia was also demonstrated. In conclusion, our results confirm that PA is a frequent cause of secondary hypertension in patients with hypokalemia, and the presence of hypertension and spontaneous hypokalemia are strong indications for PA diagnosis. Finally, we show that PA and hypokalemia are associated with an increased risk of cardiovascular events.

Entities:  

Keywords:  hypertension; hypokalemia; phenotype; potassium; regression analysis

Mesh:

Year:  2020        PMID: 32114853     DOI: 10.1161/HYPERTENSIONAHA.119.14063

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It.

Authors:  Taweesak Wannachalee; Leedor Lieberman; Adina F Turcu
Journal:  Curr Hypertens Rep       Date:  2022-02-14       Impact factor: 5.369

Review 2.  Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic Paradigm.

Authors:  Michael R Lattanzio; Matthew R Weir
Journal:  Kidney360       Date:  2020-07-23

Review 3.  Primary aldosteronism - a multidimensional syndrome.

Authors:  Adina F Turcu; Jun Yang; Anand Vaidya
Journal:  Nat Rev Endocrinol       Date:  2022-08-31       Impact factor: 47.564

Review 4.  Primary Aldosteronism: a Continuum from Normotension to Hypertension.

Authors:  Taweesak Wannachalee; Adina F Turcu
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

5.  The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.

Authors:  Jenifer M Brown; Mohammed Siddiqui; David A Calhoun; Robert M Carey; Paul N Hopkins; Gordon H Williams; Anand Vaidya
Journal:  Ann Intern Med       Date:  2020-05-26       Impact factor: 25.391

Review 6.  Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.

Authors:  Heather Wachtel; Douglas L Fraker
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 3.955

7.  Hypertension in a patient with medullary sponge kidney: A case report.

Authors:  Fengyuan Wu; Ying Zhang; Yunpeng Cheng; Yan Lu; Yinong Jiang; Wei Song
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

8.  The Cl-/HCO3- exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism.

Authors:  Aihua Wu; Martin J Wolley; Qi Wu; Richard D Gordon; Robert A Fenton; Michael Stowasser
Journal:  J Hum Hypertens       Date:  2020-11-10       Impact factor: 3.012

Review 9.  Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.

Authors:  Anand Vaidya; Robert M Carey
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

Review 10.  Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review.

Authors:  Yuta Tezuka; Yuto Yamazaki; Yasuhiro Nakamura; Hironobu Sasano; Fumitoshi Satoh
Journal:  Biomedicines       Date:  2021-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.